80 శాతం కరోనా రోగులకు ఉపయోగపడే మందుకు భారతదేశంలో అనుమతి India Approves Drug For Mild Cases
#Glenmark Pharmaceuticals Limited has announced the introduction of #Favipiravir under the brand name FabiFlu in tablet form for the treatment of mild & moderate cases in India.
Nearly 80% of all positive cases in India are under this category. #FabiFlu is India’s first oral antiviral drug for treatment of mild & moderate patients, the company said.
Glenmark’s antiviral drug Fabiflu to be used for patients with mild and moderate symptoms
“It is a significant step in the fight against virus in #india. Glenmark is leading the flight. We are not looking it as a business opportunity. The priority is to make the drug available to as many patients and save lives,” said Sujesh Vasudevan, president, India Formulations, Middle East and Africa, Glenmark Pharmaceuticals Limited in a video conference.
The company had on Friday received approval from Indian drug regulator for manufacturing and marketing of Favipiravir in oral form in India.
About SocialNewsXYZ
An Indo-American News website. It covers Gossips, Politics, Movies, Technolgy, and Sports News and Photo Galleries and Live Coverage of Events via Youtube. The website is established in 2015 and is owned by AGK FIRE INC.
80 శాతం కరోనా రోగులకు ఉపయోగపడే మందుకు భారతదేశంలో అనుమతి India Approves Drug For Mild Cases #Glenmark Pharmaceuticals Limited has announced the introduction of #Favipiravir under the brand name FabiFlu in tablet form for the treatment of mild & moderate cases in India. Nearly 80% of all positive cases in India are under this category. #FabiFlu is India’s first oral antiviral drug for treatment of mild & moderate patients, the company said. Glenmark’s antiviral drug Fabiflu to be used for patients with mild and moderate symptoms “It is a significant step in the fight against virus in #india. Glenmark is leading the flight. We are not looking it as a business opportunity. The priority is to make the drug available to as many patients and save lives,” said Sujesh Vasudevan, president, India Formulations, Middle East and Africa, Glenmark Pharmaceuticals Limited in a video conference. The company had on Friday received approval from Indian drug regulator for manufacturing and marketing of Favipiravir in oral form in India.